| Non-alcoholic fatty liver disease and dyslipidemia: an update N Katsiki, DP Mikhailidis, CS Mantzoros Metabolism 65 (8), 1109-1123, 2016 | 581 | 2016 |
| Lipid-lowering nutraceuticals in clinical practice: position paper from an International Lipid Expert Panel AFG Cicero, A Colletti, G Bajraktari, O Descamps, DM Djuric, M Ezhov, ... Nutrition reviews 75 (9), 731-767, 2017 | 544 | 2017 |
| Lifestyle recommendations for the prevention and management of metabolic syndrome: an international panel recommendation P Pérez-Martínez, DP Mikhailidis, VG Athyros, M Bullo, P Couture, ... Nutrition reviews 75 (5), 307-326, 2017 | 460 | 2017 |
| Apoptosis and acute brain ischemia in ischemic stroke D Radak, N Katsiki, I Resanovic, A Jovanovic, E Sudar-Milovanovic, ... Current vascular pharmacology 15 (2), 115-122, 2017 | 446 | 2017 |
| Leptin, cardiovascular diseases and type 2 diabetes mellitus N Katsiki, DP Mikhailidis, M Banach Acta Pharmacologica Sinica 39 (7), 1176-1188, 2018 | 328 | 2018 |
| The use of statins alone, or in combination with pioglitazone and other drugs, for the treatment of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis and related … VG Athyros, TK Alexandrides, H Bilianou, E Cholongitas, M Doumas, ... Metabolism 71, 17-32, 2017 | 309 | 2017 |
| The role of nutraceuticals in statin intolerant patients M Banach, AM Patti, RV Giglio, AFG Cicero, AG Atanasov, G Bajraktari, ... Journal of the American College of Cardiology 72 (1), 96-118, 2018 | 281 | 2018 |
| Effects of curcuminoids plus piperine on glycemic, hepatic and inflammatory biomarkers in patients with type 2 diabetes mellitus: a randomized double-blind placebo-controlled trial Y Panahi, N Khalili, E Sahebi, S Namazi, LE Simental-Mendía, M Majeed, ... Drug research 68 (07), 403-409, 2018 | 239 | 2018 |
| Pharmacotherapy of type 2 diabetes: an update J Upadhyay, SA Polyzos, N Perakakis, B Thakkar, SA Paschou, N Katsiki, ... Metabolism 78, 13-42, 2018 | 229 | 2018 |
| Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC) AJ Vallejo-Vaz, CAT Stevens, ARM Lyons, KI Dharmayat, T Freiberger, ... The Lancet 398 (10312), 1713-1725, 2021 | 220 | 2021 |
| Health benefits of the Mediterranean diet: an update of research over the last 5 years E Gotsis, P Anagnostis, A Mariolis, A Vlachou, N Katsiki, A Karagiannis Angiology 66 (4), 304-318, 2015 | 213 | 2015 |
| The fluid aspect of the Mediterranean diet in the prevention and management of cardiovascular disease and diabetes: the role of polyphenol content in moderate consumption of … P Ditano-Vázquez, JD Torres-Peña, F Galeano-Valle, AI Pérez-Caballero, ... Nutrients 11 (11), 2833, 2019 | 204 | 2019 |
| Lipoprotein subfractions in metabolic syndrome and obesity: clinical significance and therapeutic approaches D Nikolic, N Katsiki, G Montalto, ER Isenovic, DP Mikhailidis, M Rizzo Nutrients 5 (3), 928-948, 2013 | 202 | 2013 |
| Adiponectin, lipids and atherosclerosis N Katsiki, C Mantzoros, DP Mikhailidis Current opinion in lipidology 28 (4), 347-354, 2017 | 199 | 2017 |
| Cardiovascular risk across the histological spectrum and the clinical manifestations of non-alcoholic fatty liver disease: An update VG Athyros, K Tziomalos, N Katsiki, M Doumas, A Karagiannis, ... World Journal of Gastroenterology: WJG 21 (22), 6820, 2015 | 198 | 2015 |
| Resolution of non-alcoholic steatohepatitis by rosuvastatin monotherapy in patients with metabolic syndrome K Kargiotis, VG Athyros, O Giouleme, N Katsiki, E Katsiki, P Anagnostis, ... World Journal of Gastroenterology: WJG 21 (25), 7860, 2015 | 187 | 2015 |
| Lipid accumulation product and triglycerides/glucose index are useful predictors of insulin resistance M Mazidi, AP Kengne, N Katsiki, DP Mikhailidis, M Banach Journal of Diabetes and its Complications 32 (3), 266-270, 2018 | 156 | 2018 |
| The role of fibrate treatment in dyslipidemia: an overview N Katsiki, D Nikolic, G Montalto, M Banach, DP Mikhailidis, M Rizzo Current pharmaceutical design 19 (17), 3124-3131, 2013 | 150 | 2013 |
| Sodium–glucose cotransporter 2 inhibitors and inflammation in chronic kidney disease: Possible molecular pathways H Yaribeygi, AE Butler, SL Atkin, N Katsiki, A Sahebkar Journal of cellular physiology 234 (1), 223-230, 2019 | 147 | 2019 |
| Semaglutide as a promising antiobesity drug GA Christou, N Katsiki, J Blundell, G Fruhbeck, DN Kiortsis Obesity Reviews 20 (6), 805-815, 2019 | 144 | 2019 |
